Quick answer
In focal laser ablation, thin fibers carry laser energy to the tumor and heat only that area of the prostate.6 The laser can be guided by MRI, inside the scanner itself, or by ultrasound with the MRI image overlaid, including through the perineum, in the technique called TPLA.6,9 In a review of 12 studies, significant cancer came back in 15% on control biopsies.3 The European guideline considers the technique to be in the early phases of evaluation.1
What it is and how it works
Focal laser ablation is one of the focal therapy techniques, which treat only the part of the prostate where the cancer is. One or more laser fibers are placed inside the lesion, and the light energy heats the tissue around the fiber tip until it is destroyed.6
For this, the tumor has to be well located. The studies treat lesions seen on MRI and confirmed by biopsy, usually PI-RADS 3 or higher.9 A fusion biopsy is the test that links the MRI image to the sample taken.
MRI-guided or ultrasound-guided
The laser reaches the tumor in different ways, depending on the imaging that guides the fibers:
| Form | How it is done |
|---|---|
| Inside the MRI scanner | The procedure is done inside the MRI scanner, usually by radiologists6 |
| MRI-ultrasound fusion | Outside the scanner, the MRI image is overlaid on the ultrasound to guide the fibers. In a pilot study, it was done in the clinic under local anesthesia, with probes measuring the temperature inside the prostate6 |
| Through the perineum, ultrasound-guided (TPLA) | Thin needles placed through the perineum carry one or more fibers to the lesion marked on MRI, with the ultrasound showing the way9 |
TPLA stands for transperineal laser ablation. In a Dutch pilot study of 12 men, done before an already scheduled prostatectomy, the procedure was performed under local anesthesia, and the men went home after about 3 hours.7 In a French study, using more than one fiber produced larger treated areas than a single fiber.8
Studies still vary a lot in patient selection, follow-up and the definition of recurrence, which makes it hard to compare one form with another.3
What the studies show
Laser studies are mostly small and have short follow-up. The main ones:
| Study | Men | Result |
|---|---|---|
| Chicago, inside the MRI scanner (2016) | 27, most with Gleason 6 | At 12 months, cancer in 37% on biopsy: 11% in the treated area and 30% outside it4 |
| New York, inside the MRI scanner (2021) | 36, 30 followed for about 6 years | 83% free of treatment failure; of these, 40% had cancer come back in the treated area, and almost all had another partial ablation5 |
| TPLA registry, Europe and United States (2026) | 195, with 206 lesions | Clinically significant cancer back in the treated area in 17% of lesions at 12 months9 |
| Review of 12 studies (2026) | 421 | Clinically significant cancer back in 15% on control biopsies3 |
In the New York study, "failure" meant needing whole-gland or hormone treatment, developing metastasis or dying of the cancer. Two men developed metastasis, and none died of the cancer.5 The authors conclude that cancer coming back, inside or outside the treated area, is common and often requires further treatment.5
In the TPLA registry, a PSA density above 0.16 before treatment and an abnormal MRI afterwards were linked to the cancer coming back.9
Effects on urine, erections and complications
- Urine: in the review of 12 studies, urinary function did not change significantly after laser.3 In the TPLA pilot study, urinary symptoms were mild and usually settled within a week.7
- Erections: the review found a small decline in sexual function, statistically significant but of no clinical importance.3 With TPLA, erections worsened in the first week and returned to baseline by 4 weeks in the pilot study.7 In a French study, the erection score dropped slightly at 12 months.8
- Complications: in a pilot study using image fusion, none of the 10 men treated had a serious complication.6 In the French study of 55 men, one developed a fistula between the prostate and the rectum and needed surgery.8
The pages on continence and on erections and ejaculation compare these effects with those of other treatments.
Follow-up and if the cancer comes back
After laser treatment, follow-up uses PSA, MRI and biopsy. In the TPLA registry, an abnormal control MRI was highly able to point to men whose cancer had come back in the treated area.9
If the cancer comes back, the options include another ablation, radical prostatectomy or radiotherapy. In the Dutch pilot study, done before an already scheduled prostatectomy, the surgeons reported that the ablation did not hinder the operation.7
What the guidelines say
| Guideline | What it says |
|---|---|
| European (EAU, 2026) | Laser ablation is among the techniques in the early phases of evaluation. For low risk, focal therapy is likely overtreatment and should not be used outside trials. For intermediate risk, offer it only within clinical trials or registries (strong recommendation)1 |
| American (AUA/ASTRO, 2026) | Tell patients with low- or intermediate-risk cancer that focal therapy remains investigational, without high-quality data comparing it with standard treatments. For high risk, do not recommend it outside a clinical trial2 |
The review of 12 studies concludes that cancer control with laser appears comparable to other focal therapies, but that high-quality comparative studies are lacking.3 For low-risk disease, the option the guidelines recommend is active surveillance.1
When a second opinion helps
If you have been offered focal laser treatment or are researching it, it is worth talking to another specialist:
- If your cancer is low risk and active surveillance has not been discussed
- If the MRI and biopsy do not make clear where the tumor is or whether there are other foci
- If you want to compare focal therapy with surgery and radiotherapy, which have longer follow-up
- If your PSA or MRI has changed after focal therapy
A second opinion can be done entirely online, in English, with your test results sent in advance. The surgery or radiotherapy page helps compare whole-gland treatments.
Send your case
If you are having your prostate checked, with a raised PSA, an MRI or a biopsy, or you have already been diagnosed and would like my opinion before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.
Frequently asked questions
What is focal laser ablation of the prostate?+
It is a focal therapy in which laser fibers are placed inside the tumor and heat only that area of the prostate, guided by MRI or ultrasound.6,9 The European guideline still considers the technique to be in the early phases of evaluation.1
What is the difference between MRI-guided and ultrasound-guided laser?+
In its original form, the laser is applied inside the MRI scanner, usually by radiologists. Later, forms outside the scanner appeared, including in the clinic, guided by ultrasound with the MRI image overlaid.6,9 Studies still vary a lot in patient selection and follow-up, which makes the results hard to compare.3
What is TPLA?+
TPLA stands for transperineal laser ablation guided by ultrasound. Thin needles placed through the skin between the scrotum and the anus carry one or more laser fibers to the lesion seen on MRI.9 In a pilot study, men went home after about 3 hours, under local anesthesia.7
What are the results of focal laser ablation?+
In a review of 12 studies with 421 men, clinically significant cancer came back in 15% on control biopsies.3 In a four-center registry of TPLA, it came back in the treated area in 17% of lesions at 12 months.9 Studies are still small with short follow-up.3
Does laser ablation affect erections and urine?+
In the review of 12 studies, urinary function did not change significantly, and sexual function showed a small decline of no clinical importance.3 In a TPLA study, erections worsened in the first week and returned to baseline by 4 weeks.7
What are the complications of focal laser ablation?+
In the TPLA pilot study, side effects were mild and short-lived, such as urinary symptoms in the first week.7 But serious complications can happen. In a series of 55 men, one developed a fistula between the prostate and the rectum and needed surgery.8
What do the guidelines say about focal laser ablation?+
The European guideline places laser ablation among the techniques in the early phases of evaluation and recommends focal therapy for intermediate-risk disease only within clinical trials or registries.1 The American guideline says focal therapy remains investigational for low- and intermediate-risk disease.2
References
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: treatment. European Association of Urology; 2026. EAU
- Eastham JA, Barocas DA, Chu CE, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026). J Urol. 2026;216(1):2-11. PubMed
- Bushati Y, Guo AA, Muston BT, et al. Focal laser ablation in prostate cancer: a systematic review and meta-analysis. BJU Int. 2026;137(2):251-259. PubMed
- Eggener SE, Yousuf A, Watson S, et al. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer. J Urol. 2016;196(6):1670-1675. PubMed
- Chao B, Lepor H. 5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer. Urology. 2021;155:124-129. PubMed
- Natarajan S, Jones TA, Priester AM, et al. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol. 2017;198(4):839-847. PubMed
- van Riel LAMJG, van Kollenburg RAA, Vis AN, et al. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study. Eur Urol Open Sci. 2022;39:48-54. PubMed
- Cornud F, de Bie K, van Riel L, et al. MRI-directed Micro-US-guided Transperineal Focal Laser Ablation for Localized Prostate Cancer: A 1-year Follow-up Study. Radiology. 2024;313(3):e233371. PubMed
- de Bie KCC, Cornud FC, Walser EM, et al. One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study. Radiology. 2026;319(3):e251658. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation5.0186 Google reviews
